+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "DNA Vaccines"

From
From
From
From
From
From
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
  • Global
From
Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

  • Report
  • November 2021
  • 1184 Pages
  • Global
From
From
DNA Vaccines Market - Forecast (2022 - 2027) - Product Thumbnail Image

DNA Vaccines Market - Forecast (2022 - 2027)

  • Report
  • January 2022
  • 121 Pages
  • Global
From
Global Gene Synthesis Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Gene Synthesis Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
Loading Indicator

DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines. DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola. Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more